Eye tracking - The overlooked method to measure cognition in neurodegeneration?
Eye tracking - The overlooked method to measure cognition in neurodegeneration?
Eye tracking (ET) studies are becoming increasingly popular due to rapid methodological and technological advances as well as the development of cost efficient and portable eye trackers. Although historically ET has been mostly employed in psychophysics or developmental cognition studies, there is also promising scope to use ET for movement disorders and measuring cognitive processes in neurodegeneration. Particularly, ET can be a powerful tool for cognitive and neuropsychological assessments of patients with pathologies affecting motor and verbal abilities, as tasks can be adapted without requiring motor (except eye movements) or verbal responses. In this review, we will examine the existing evidence of ET methods in neurodegenerative conditions and its potential clinical impact for cognitive assessment. We highlight that current evidence for ET is mostly focused on diagnostics of cognitive impairments in neurodegenerative disorders, where it is debatable whether it has any more sensitivity or specificity than existing cognitive assessments. By contrast, there is currently a lack of ET studies in more advanced disease stages, when patients’ motor and verbal functions can be significantly affected, and standard cognitive assessments are challenging or often not possible. We conclude that ET is a promising method not only for cognitive diagnostics but more importantly, for potential cognitive disease tracking in progressive neurodegenerative conditions.
APA, Bueno
35ce9296-ad9d-4e4c-9314-9bd7ecbc9d94
JR, Sato
0da0fe45-adab-4cb9-953f-dab6ff26af39
Hornberger, M
a48c1c63-422a-4c11-9a51-c7be0aa3026d
1 September 2019
APA, Bueno
35ce9296-ad9d-4e4c-9314-9bd7ecbc9d94
JR, Sato
0da0fe45-adab-4cb9-953f-dab6ff26af39
Hornberger, M
a48c1c63-422a-4c11-9a51-c7be0aa3026d
Abstract
Eye tracking (ET) studies are becoming increasingly popular due to rapid methodological and technological advances as well as the development of cost efficient and portable eye trackers. Although historically ET has been mostly employed in psychophysics or developmental cognition studies, there is also promising scope to use ET for movement disorders and measuring cognitive processes in neurodegeneration. Particularly, ET can be a powerful tool for cognitive and neuropsychological assessments of patients with pathologies affecting motor and verbal abilities, as tasks can be adapted without requiring motor (except eye movements) or verbal responses. In this review, we will examine the existing evidence of ET methods in neurodegenerative conditions and its potential clinical impact for cognitive assessment. We highlight that current evidence for ET is mostly focused on diagnostics of cognitive impairments in neurodegenerative disorders, where it is debatable whether it has any more sensitivity or specificity than existing cognitive assessments. By contrast, there is currently a lack of ET studies in more advanced disease stages, when patients’ motor and verbal functions can be significantly affected, and standard cognitive assessments are challenging or often not possible. We conclude that ET is a promising method not only for cognitive diagnostics but more importantly, for potential cognitive disease tracking in progressive neurodegenerative conditions.
This record has no associated files available for download.
More information
Published date: 1 September 2019
Identifiers
Local EPrints ID: 504875
URI: http://eprints.soton.ac.uk/id/eprint/504875
ISSN: 0028-3932
PURE UUID: d18aaea7-954e-4e80-834a-ac53a5d10cb0
Catalogue record
Date deposited: 19 Sep 2025 16:52
Last modified: 20 Sep 2025 02:31
Export record
Altmetrics
Contributors
Author:
Bueno APA
Author:
Sato JR
Author:
M Hornberger
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics